Skip to Content
scroll

Healius Ltd (HLS) $4.48

HLS has corrected 22% from its 2022 high as sentiment towards growth stocks has deteriorated on rising inflation – the same old story. However HLS has also encountered extra selling as the demand for COVID testing has fallen away as more people and importantly the government become comfortable with RATs. We feel this selling pressure is likely to continue at least short-term even after Treasurer Frydenberg made COVID tests for work tax deductible – HLS currently processes around 40,000 test a day. In our opinion value will return to HLS back around $4 hence we’re happy to be observers at this stage.

HLS
MM is neutral HLS around $4.50
Add To Hit List
chart
image description
Healius Ltd (HLS)
Back to top